As of 2026-09-10, the Relative Valuation of Meridian Bioscience Inc (VIVO) is (23.20) USD. This relative valuation is based on P/E multiples. With the latest stock price at 4.15 USD, the upside of Meridian Bioscience Inc based on Relative Valuation is -659.0%.
The range of the Relative Valuation is (21.56) - (25.31) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 28.3x - 38.3x | 32.6x |
| Forward P/E multiples | 26.1x - 33.2x | 28.2x |
| Fair Price | (21.56) - (25.31) | (23.20) |
| Upside | -619.5% - -709.9% | -659.0% |
| Date | P/E |
| 2026-09-09 | -5.45 |
| 2026-09-08 | -5.34 |
| 2026-09-04 | -5.11 |
| 2026-09-03 | -5.15 |
| 2026-09-02 | -5.09 |
| 2026-09-01 | -5.00 |
| 2026-08-31 | -5.34 |
| 2026-08-28 | -5.33 |
| 2026-08-27 | -5.62 |
| 2026-08-26 | -5.52 |
| 2026-08-25 | -5.47 |
| 2026-08-24 | -5.71 |
| 2026-08-21 | -5.72 |
| 2026-08-20 | -5.53 |
| 2026-08-19 | -5.72 |
| 2026-08-18 | -5.78 |
| 2026-08-17 | -6.43 |
| 2026-08-14 | -6.39 |
| 2026-08-13 | -6.02 |
| 2026-08-12 | -5.54 |
| 2026-08-11 | -5.32 |
| 2026-08-10 | -5.17 |
| 2026-08-07 | -5.30 |
| 2026-08-06 | -5.03 |
| 2026-08-05 | -4.96 |
| 2026-08-04 | -5.12 |
| 2026-08-03 | -4.90 |
| 2026-07-31 | -4.69 |
| 2026-07-30 | -4.65 |
| 2026-07-29 | -4.16 |
| 2026-07-28 | -5.09 |
| 2026-07-27 | -5.14 |
| 2026-07-24 | -5.60 |
| 2026-07-23 | -5.13 |
| 2026-07-22 | -5.12 |
| 2026-07-21 | -5.36 |
| 2026-07-20 | -4.97 |
| 2026-07-17 | -5.05 |
| 2026-07-16 | -5.13 |
| 2026-07-15 | -5.79 |
| 2026-07-14 | -6.18 |
| 2026-07-13 | -5.97 |
| 2026-07-10 | -6.86 |
| 2026-07-09 | -6.05 |
| 2026-07-08 | -5.79 |
| 2026-07-07 | -5.85 |
| 2026-07-06 | -6.31 |
| 2026-07-02 | -6.14 |
| 2026-07-01 | -6.51 |
| 2026-06-30 | -6.79 |